» Articles » PMID: 37869513

Cortical Structural Differences Following Repeated Ayahuasca Use Hold Molecular Signatures

Overview
Journal Front Neurosci
Date 2023 Oct 23
PMID 37869513
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Serotonergic psychedelics such as ayahuasca are reported to promote both structural and functional neural plasticity via partial 5-HT agonism. However, little is known about how these molecular mechanisms may extend to repeated psychedelic administration in humans, let alone neuroanatomy. While early evidence suggests localised changes to cortical thickness in long-term ayahuasca users, it is unknown how such findings may be reflected by large-scale anatomical brain networks comprising cytoarchitecturally complex regions.

Methods: Here, we examined the relationship between cortical gene expression markers of psychedelic action and brain morphometric change following repeated ayahuasca usage, using high-field 7 Tesla neuroimaging data derived from 24 members of an ayahuasca-using church (Santo Daime) and case-matched controls.

Results: Using a morphometric similarity network (MSN) analysis, repeated ayahuasca use was associated with a spatially distributed cortical patterning of both structural differentiation in sensorimotor areas and de-differentiation in transmodal areas. Cortical MSN remodelling was found to be spatially correlated with dysregulation of 5-HT gene expression as well as a broader set of genes encoding target receptors pertinent to ayahuasca's effects. Furthermore, these associations were similarly interrelated with altered gene expression of specific transcriptional factors and immediate early genes previously identified in preclinical assays as relevant to psychedelic-induced neuroplasticity.

Conclusion: Taken together, these findings provide preliminary evidence that the molecular mechanisms of psychedelic action may scale up to a macroscale level of brain organisation . Closer attention to the role of cortical transcriptomics in structural-functional coupling may help account for the behavioural differences observed in experienced psychedelic users.

Citing Articles

Psychedelic-Induced Neural Plasticity: A Comprehensive Review and a Discussion of Clinical Implications.

Weiss F, Magnesa A, Gambini M, Gurrieri R, Annuzzi E, Elefante C Brain Sci. 2025; 15(2).

PMID: 40002450 PMC: 11853016. DOI: 10.3390/brainsci15020117.


Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.

Egger K, Aicher H, Cumming P, Scheidegger M Cell Mol Life Sci. 2024; 81(1):395.

PMID: 39254764 PMC: 11387584. DOI: 10.1007/s00018-024-05353-6.

References
1.
Blainey M . Forbidden therapies: Santo Daime, ayahuasca, and the prohibition of entheogens in Western society. J Relig Health. 2014; 54(1):287-302. DOI: 10.1007/s10943-014-9826-2. View

2.
Olson D . Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics. J Exp Neurosci. 2018; 12:1179069518800508. PMC: 6149016. DOI: 10.1177/1179069518800508. View

3.
Sampedro F, de la Fuente Revenga M, Valle M, Roberto N, Dominguez-Clave E, Elices M . Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities. Int J Neuropsychopharmacol. 2017; 20(9):698-711. PMC: 5581489. DOI: 10.1093/ijnp/pyx036. View

4.
Cano M, Martinez-Zalacain I, Bernabeu-Sanz A, Contreras-Rodriguez O, Hernandez-Ribas R, Via E . Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study. Transl Psychiatry. 2017; 7(2):e1023. PMC: 5438019. DOI: 10.1038/tp.2016.267. View

5.
Ly C, Greb A, Cameron L, Wong J, Barragan E, Wilson P . Psychedelics Promote Structural and Functional Neural Plasticity. Cell Rep. 2018; 23(11):3170-3182. PMC: 6082376. DOI: 10.1016/j.celrep.2018.05.022. View